$37.75
1.40% yesterday
NYSE, Oct 01, 10:00 pm CET
ISIN
US09250W1071
Symbol
BME

BlackRock Health Sciences Trust Stock price

$37.75
+1.02 2.78% 1M
-0.60 1.56% 6M
-0.18 0.47% YTD
-4.27 10.16% 1Y
-1.91 4.82% 3Y
-5.19 12.09% 5Y
+3.12 9.01% 10Y
+20.59 120.04% 20Y
NYSE, Closing price Wed, Oct 01 2025
+0.52 1.40%
ISIN
US09250W1071
Symbol
BME

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$270.0k
Cash
$10.0k
Shares outstanding
13.0m
Valuation (TTM | estimate)
P/E
20.2 | -
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$2.90
Yield 1Y | 5Y
7.8% | 6.1%
Growth 1Y | 5Y
13.4% | 3.9%
Payout 1Y | 3Y
144.4% | 586.9%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$7.6m | -
EBITDA
- | -
EBIT
$930.0k | -
Net Income
$24.0m | -
Free Cash Flow
$66.0m
Growth (TTM | estimate)
Revenue
-7.7% | -
EBITDA
- | -
EBIT
-53.5% | -
Net Income
19.9% | -
Free Cash Flow
106.3%
Margin (TTM | estimate)
Gross
100.0%
EBITDA
- | -
EBIT
12.3%
Net
317.0% | -
Free Cash Flow
871.9%
Financial Health
Equity Ratio
99.3%
Return on Equity
4.2%
ROCE
0.2%
ROIC
-
Debt/Equity
0.0
More
EPS
$1.8
FCF per Share
$5.1
Short interest
0.1%
Employees
-
Rev per Employee
-
Show more

Is BlackRock Health Sciences Trust a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Financial data from BlackRock Health Sciences Trust

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
7.57 7.57
8% 8%
100%
- Direct Costs - -
-
-
7.57 7.57
92% 92%
100%
- Selling and Administrative Expenses 6.58 6.58
7% 7%
87%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 0.93 0.93
54% 54%
12%
Net Profit 24 24
20% 20%
317%

In millions USD.

Don't miss a Thing! We will send you all news about BlackRock Health Sciences Trust directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BlackRock Health Sciences Trust Stock News

Positive
Seeking Alpha
about 10 hours ago
BlackRock Health Sciences Trust shares have declined 12.4% in the past year, underperforming the broader market rally. BME currently trades at an 8.3% discount to NAV, significantly wider than its five-year average discount of 2.48%. Despite an attractive 8.6% dividend yield, BME's low net investment income raises concerns about the sustainability of its distributions.
Neutral
Business Wire
one day ago
NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Divid...
Positive
Seeking Alpha
18 days ago
Call writing closed-end funds can offer attractive monthly distributions, along with the opportunity to trade at discounts to their historical net asset values. That discount can create an opportunity for investors to enter at attractive prices while getting the underlying portfolio on 'sale.' Today, we are looking at two CEFs that provide monthly distributions and are presenting relatively att...
More BlackRock Health Sciences Trust News

Company Profile

BlackRock Health Sciences Trust is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The company was founded on March 31, 2005 and is headquartered in Wilmington, DE.

Head office United States
CEO John Perlowski
Founded 2005
Website www.blackrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today